Cargando…
Application of Monoclonal Antibody Drugs in Treatment of COVID-19: a Review
Coronavirus infection can have various degrees of severity and outcomes. In some cases, it causes excessive production of pro-inflammatory cytokines, a so-called cytokine storm, leading to acute respiratory distress syndrome. Unfortunately, the exact pathophysiology and treatment, especially for sev...
Autores principales: | Kirillova, Aleksandra, Lado, Anna, Blatt, Nataliya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198616/ https://www.ncbi.nlm.nih.gov/pubmed/35729973 http://dx.doi.org/10.1007/s12668-022-00997-9 |
Ejemplares similares
-
Application of Extracorporeal Apheresis in Treatment of COVID-19: a Rapid Review
por: Lezhnina, Arina, et al.
Publicado: (2022) -
Role of monoclonal antibody drugs in the treatment of COVID-19
por: Ucciferri, Claudio, et al.
Publicado: (2020) -
Monoclonal antibodies as treatment for COVID-19
por: Medina Gamero, A., et al.
Publicado: (2022) -
A Patent Review on the Therapeutic Application of Monoclonal Antibodies in COVID-19
por: Asdaq, Syed Mohammed Basheeruddin, et al.
Publicado: (2021) -
Neutralizing monoclonal antibodies for treatment of COVID-19
por: Taylor, Peter C., et al.
Publicado: (2021)